167 related articles for article (PubMed ID: 15491811)
21. An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots.
Deadman CM; Kellaway IW; Yasin M; Dickinson PA; Murdan S
J Control Release; 2007 Sep; 122(1):79-85. PubMed ID: 17638603
[TBL] [Abstract][Full Text] [Related]
22. Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles.
Zweers ML; Engbers GH; Grijpma DW; Feijen J
J Control Release; 2006 Sep; 114(3):317-24. PubMed ID: 16884807
[TBL] [Abstract][Full Text] [Related]
23. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
24. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation in vitro and vivo of copoly (lactic/glycolic) acid microspheres containing norethisterone.
Zhou Z; Zhou M; Wang S; Lin F; Shan W
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(1):71-84. PubMed ID: 8461438
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
Gangadharam PR; Geeta N; Hsu YY; Wise DL
Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
[TBL] [Abstract][Full Text] [Related]
27. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
[TBL] [Abstract][Full Text] [Related]
28. Poly (DL-lactide-co-glycolide) based delivery systems for vaccines and drugs.
Dhiman N; Dutta M; Khuller GK
Indian J Exp Biol; 2000 Aug; 38(8):746-52. PubMed ID: 12557904
[TBL] [Abstract][Full Text] [Related]
29. [The study of the in vivo-in vitro correlation of the naftopidil sustained-release tablet in dog].
Jia Y; Jiang X; Ding J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):826-8, 843. PubMed ID: 17002117
[TBL] [Abstract][Full Text] [Related]
30. A mathematical model for interpreting in vitro rhGH release from laminar implants.
Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
[TBL] [Abstract][Full Text] [Related]
31. [An experimental study on ectopic osteogenesis of autologous micromorselized bone compounded with slow-released rhBMP-2/PLGA microsphere].
Ji Y; Yan J; Xu G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1184-90. PubMed ID: 18069471
[TBL] [Abstract][Full Text] [Related]
32. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
33. Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers.
Hanafy AF; El-Egaky AM; Mortada SA; Molokhia AM
Drug Discov Ther; 2009 Dec; 3(6):287-95. PubMed ID: 22495663
[TBL] [Abstract][Full Text] [Related]
34. A nanofibrous sheet-based system for linear delivery of nifedipine.
Park CG; Kim E; Park M; Park JH; Choy YB
J Control Release; 2011 Feb; 149(3):250-7. PubMed ID: 21035511
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
36. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
37. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
Tanaka Y; Miyazaki Y; Yakou S; Takayama K
Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
40. Three-layered microcapsules as a long-term sustained release injection preparation.
Ito Y; Ochii Y; Fukushima K; Sugioka N; Takada K
Int J Pharm; 2010 Jan; 384(1-2):53-9. PubMed ID: 19782737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
